Leonor Ribeiro
Impact in
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Cancer survivorship and care
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 13
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 3
- Cancer Diagnosis and Treatment 2
-
- Head and Neck Cancer Studies 5
- Co-authors
- Luís Costa (12 shared papers)Nandini Verma (1 shared paper)Mark M. Moasser (1 shared paper)Bijesh George (1 shared paper)Marcia R. Campbell (1 shared paper)M. Radhakrishna Pillai (1 shared paper)Rakesh Kumar (1 shared paper)Ricardo A. Pires (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Nature Communications (1 paper)Clinical Breast Cancer (1 paper)ESMO Open (1 paper)Advances in cancer research (1 paper)
- Partner nations
- PortugalSpainUnited States
In The Last Decade
Leonor Ribeiro
22 papers receiving 159 citations
Peers
Comparison fields: 5 of 55
- Oncology 62
- Hepatology 17
- Otorhinolaryngology 9
- Cancer Research 20
- Pulmonary and Respiratory Medicine 27
Countries citing papers authored by Leonor Ribeiro
This map shows the geographic impact of Leonor Ribeiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonor Ribeiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonor Ribeiro more than expected).
Fields of papers citing papers by Leonor Ribeiro
This network shows the impact of papers produced by Leonor Ribeiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonor Ribeiro. The network helps show where Leonor Ribeiro may publish in the future.
Co-authors
The 25 scholars most cited alongside Leonor Ribeiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 40 | |
| 2 | 2015 | 20 | |
| 3 | 2022 | 18 | |
| 4 | 2023 | 9 | |
| 5 | 2020 | 9 | |
| 6 | 2023 | 8 | |
| 7 | 2016 | 8 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 6 | |
| 10 | 2019 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2020 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2020 | 3 | |
| 16 | 2016 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2024 | 1 |
About Leonor Ribeiro
Leonor Ribeiro is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 24 papers that have together received 161 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (5 papers), HER2/EGFR in Cancer Research (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer Treatment and Pharmacology (3 papers), Breast Cancer Treatment Studies (3 papers), Cancer Diagnosis and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (62 citations), Hepatology (17 citations), Otorhinolaryngology (9 citations), Cancer Research (20 citations) and Pulmonary and Respiratory Medicine (27 citations). Leonor Ribeiro has collaborated with scholars based in Portugal, Spain and United States. Frequent co-authors include Luís Costa, Nandini Verma, Mark M. Moasser, Bijesh George, Marcia R. Campbell, M. Radhakrishna Pillai, Rakesh Kumar, Ricardo A. Pires, Mafalda Casa-Nova and Margarida Matias. Their work appears in journals such as Annals of Oncology, Nature Communications, Clinical Breast Cancer, ESMO Open and Advances in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.